Koninklijke Wessanen N.V.:企業の戦略・SWOT・財務情報

◆英語タイトル:Koninklijke Wessanen N.V. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3784
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Koninklijke Wessanen N.V. – Strategy, SWOT and Corporate Finance Report
Summary

Koninklijke Wessanen N.V. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Koninklijke Wessanen N.V. (Wessanen) produces and markets healthy and sustainable food products. The company’s product offerings include tea, coffee, dairy alternatives, breakfast cereals, sweet spreads, sweet snacks, veggie meals, chocolate coated cereal cakes, meat replacers, breads and biscuits alternatives among others. These products are marketed under well-known local and European brands such as Allos, Alter Eco, Bjorg, Destination, Mrs Crimble’s, El Graner, Whole Earth, Kallo, Isola Bio, Gayelord Hause, Zonnatura, Bonneterre, Clipper and Tartex, among others. The company primarily operates in Europe and has manufacturing facilities in the UK, France, Germany, Italy and Spain. Wessanen is headquartered in Amsterdam, the Netherlands.

Scope

- Detailed information on Koninklijke Wessanen N.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Koninklijke Wessanen N.V. in the form of a SWOT analysis
- An in-depth view of the business model of Koninklijke Wessanen N.V. including a breakdown and examination of key business segments
- Intelligence on Koninklijke Wessanen N.V.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Koninklijke Wessanen N.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Koninklijke Wessanen N.V. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Koninklijke Wessanen N.V. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Koninklijke Wessanen N.V.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Koninklijke Wessanen N.V.: Company Overview 8
Koninklijke Wessanen N.V.: Overview and Key Facts 8
Koninklijke Wessanen N.V.: Overview 8
Koninklijke Wessanen N.V.: Key Facts 8
Koninklijke Wessanen N.V.: Key Employees 10
Koninklijke Wessanen N.V.: Key Employee Biographies 11
Koninklijke Wessanen N.V.: Major Products and Services 12
Koninklijke Wessanen N.V.: Company History 13
Koninklijke Wessanen N.V.: Management Statement 16
Koninklijke Wessanen N.V.: Locations and Subsidiaries 18
Koninklijke Wessanen N.V.: Key Competitors 20
Koninklijke Wessanen N.V.: Company Analysis 21
Koninklijke Wessanen N.V.: Business Description 21
Koninklijke Wessanen N.V.: SWOT Analysis 22
Koninklijke Wessanen N.V.: SWOT Overview 22
Koninklijke Wessanen N.V.: Strengths 22
Koninklijke Wessanen N.V.: Weaknesses 23
Koninklijke Wessanen N.V.: Opportunities 23
Koninklijke Wessanen N.V.: Threats 24
Koninklijke Wessanen N.V.: Corporate Financial Deals Activity 25
Koninklijke Wessanen N.V.: Financial Deals Overview 25
Koninklijke Wessanen N.V.: Targets and Partners 26
Koninklijke Wessanen N.V.: Top Deals 2014 – 2018YTD* 27
Koninklijke Wessanen N.V.: Advisors 28
Koninklijke Wessanen N.V.: Top Legal Advisors 28
Koninklijke Wessanen N.V.: Top Financial Advisors 28
Koninklijke Wessanen N.V.: Mergers and Acquisitions 29
Koninklijke Wessanen N.V.: Divestments 30
Koninklijke Wessanen N.V.: Recent Developments 31
Koninklijke Wessanen N.V.: News and Events Summary 31
Koninklijke Wessanen N.V.: Business Expansion 32
Koninklijke Wessanen N.V.: Corporate Governance 32
Koninklijke Wessanen N.V.: Financial Performance 33
Koninklijke Wessanen N.V.: Regulatory and Legal Events 34
Appendix 35
Contact Us 35
Methodology 35
About MarketLine 36

List of Tables
Table 1: Koninklijke Wessanen N.V.: Key Facts
Table 2: Koninklijke Wessanen N.V.: Key Employees
Table 3: Koninklijke Wessanen N.V.: Locations and Subsidiaries
Table 4: Koninklijke Wessanen N.V.: Key Competitors
Table 5: Koninklijke Wessanen N.V.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Koninklijke Wessanen N.V.: M&A Average Deal Size - Value (US$m)
Table 7: Koninklijke Wessanen N.V.: Targets and Partners
Table 8: Koninklijke Wessanen N.V.: Top Deals 2014 - 2018YTD*
Table 9: Koninklijke Wessanen N.V.: Legal Advisor Ranking by Value (US$m)
Table 10: Koninklijke Wessanen N.V.: Financial Advisor Ranking by Value (US$m)
Table 11: Koninklijke Wessanen N.V.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Koninklijke Wessanen N.V.: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Koninklijke Wessanen N.V.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 14: Koninklijke Wessanen N.V.: Divestments by Geography (2014 - YTD*2018)
Table 15: Koninklijke Wessanen N.V.: News and Events Summary
Table 16: Koninklijke Wessanen N.V.: Business Expansion
Table 17: Koninklijke Wessanen N.V.: Corporate Governance
Table 18: Koninklijke Wessanen N.V.: Financial Performance
Table 19: Koninklijke Wessanen N.V.: Regulatory and Legal Events

List of Figures
Figure 1: Koninklijke Wessanen N.V.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Koninklijke Wessanen N.V.: M&A Average Deal Size - Value (US$m)
Figure 3: Koninklijke Wessanen N.V.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Koninklijke Wessanen N.V.: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Koninklijke Wessanen N.V.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: Koninklijke Wessanen N.V.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Koninklijke Wessanen N.V.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aohata Corporation:企業の戦略・SWOT・財務情報
    Aohata Corporation - Strategy, SWOT and Corporate Finance Report Summary Aohata Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CVR Energy, Inc.:企業の戦略・SWOT・財務分析
    CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • TE Connectivity Ltd.:企業の戦略・SWOT・財務情報
    TE Connectivity Ltd. - Strategy, SWOT and Corporate Finance Report Summary TE Connectivity Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Advicenne SA (ADVIC):製薬・医療:M&Aディール及び事業提携情報
    Summary Advicenne SA (Advicenne) is a developer of pediatric medicines. The company offers product portfolio such as ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of micro-tablets for renal tubulopathies. It p …
  • Ashapura Minechem Ltd.:企業の戦略・SWOT・財務分析
    Ashapura Minechem Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ashapura Minechem Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • EnergySolutions, Inc.:企業の戦略・SWOT・財務情報
    EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Under Armour, Inc.:企業の戦略・SWOT・財務情報
    Under Armour, Inc. - Strategy, SWOT and Corporate Finance Report Summary Under Armour, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • FirstGroup plc (FGP):企業の財務・戦略的SWOT分析
    FirstGroup plc (FGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ValiRx Plc (VAL):医療機器:M&Aディール及び事業提携情報
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing …
  • FTS International Services LLC:企業の戦略的SWOT分析
    FTS International Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Acura Pharmaceuticals Inc (ACUR)-医療機器分野:企業M&A・提携分析
    Summary Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops, and commercializes tamper-resistant products to prevent the abuse and misuse of medication. The company’s proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tamp …
  • Berry Global Group, Inc.:企業のM&A・事業提携・投資動向
    Berry Global Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Berry Global Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Jindal Power Ltd:電力:M&Aディール及び事業提携情報
    Summary Jindal Power Ltd (JPL) a subsidiary of Jindal Steel & Power Ltd, is a power generation company that builds and operates power plants. The company offers implementation, operation and planning of thermal power, hydroelectric and renewable energy power plants. Its hydroelectric projects includ …
  • GlySens Inc:医療機器:M&Aディール及び事業提携情報
    Summary GlySens Inc (GlySens) is a medical device company that offers glucose monitoring systems. The company develops GlySens ICGM system, a fully-implanted continuous glucose monitoring system intended to improve the lives of people with diabetes. GlySens offers continuous glucose sensor, which ha …
  • Fluidigm Corp (FLDM)-製薬・医療分野:企業M&A・提携分析
    Summary Fluidigm Corp (Fluidigm) formerly known as Mycometrix Corporation, is a biotechnology company which manufactures life-science tools and creates technologies based on microfluidics and mass cytometry. The company’s products systems include biomark HD system, access array system, C1 system, ca …
  • Swissport Tanzania Limited:企業の戦略・SWOT・財務分析
    Swissport Tanzania Limited - Strategy, SWOT and Corporate Finance Report Summary Swissport Tanzania Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Harvard Bioscience Inc (HBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets scientific instruments systems and lab consumables. The company’s product portfolio encompasses physiology, cell, molecular instruments products; electrophysiology products; and laboratory products and supplies. I …
  • Penske Corporation:企業の戦略的SWOT分析
    Penske Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Yanzhou Coal Mining Co Ltd:戦略・SWOT・企業財務分析
    Yanzhou Coal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanzhou Coal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆